Edaravone for the treatment of amyotrophic lateral sclerosis

H Yoshino - Expert Review of Neurotherapeutics, 2019 - Taylor & Francis
Introduction: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disorder that affects all
skeletal muscles, leading to death, mostly within 2–4 years from onset. To date, the anti …
被引用次数：99 相关文章

Edaravone for the treatment of amyotrophic lateral sclerosis.

H Yoshino - Expert Review of Neurotherapeutics, 2019 - europepmc.org
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a progressive fatal disorder that
affects all skeletal muscles, leading to death, mostly within 2-4 years from onset. To date, the …

[引用][C] Edaravone for the treatment of amyotrophic lateral sclerosis

H Yoshino - Expert Review of Neurotherapeutics, 2019 - cir.nii.ac.jp
Edaravone for the treatment of amyotrophic lateral sclerosis | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本をさがす 日本の …

Edaravone for the treatment of amyotrophic lateral sclerosis

H Yoshino - Expert review of neurotherapeutics, 2019 - pubmed.ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a progressive fatal disorder that affects all skeletal
muscles, leading to death, mostly within 2-4 years from onset. To date, the anti-glutamatergic …